RDHL

SEC filing RDHL Files Form 6-K, No Material Information Disclosed

5d ago

SEC filing RDHL Reports $120M Revenue, $15M Net Income, +25% YoY Growth, Announces $50M R&D Expansion

33d ago

Insider trade Sale by Gilead Raday (Chief Operating Officer)

39d ago

Insider trade Sale by Gilead Raday (Chief Operating Officer)

40d ago

SEC filing RDHL Reports $120M Revenue, $15M Net Income, +25% YoY Growth, Announces $50M R&D Expansion

41d ago

SEC filing RDHL Reports $12.4M Revenue, $0.08 EPS, +18% YoY Growth, Announces $50M R&D Expansion

89d ago

News Redox Bio-Nutrients becomes First Company to have Two Certified Biostimulant Products

133d ago

News RedHill Biopharma Receives Nasdaq Staff Determination Notification

153d ago